Region: All Regions > Global
Category: All Categories > Reports By Country
(55160 reports matching your criteria)
5  6  7  8    10    12  13  14  
Contact Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Contact Dermatitis. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Contraception-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Contraception. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Contraception. ...  |  read more...
USD 2,000
Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... and marketed drugs across the Cutaneous T-Cell Lymphoma. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions ...  |  read more...
USD 2,000
Insomnia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Insomnia. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Insomnia. ...  |  read more...
USD 2,000
Irritable Bowel Syndrome-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... and marketed drugs across the Irritable Bowel Syndrome. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions ...  |  read more...
USD 2,000
Sony Corp in Toys and Games (World)
2/6/2015 | published by: Euromonitor International
... work to remain at the cutting edge of innovation in video games, including the successful launch of its new generation console, PS4, and the development of its cloud-based game streaming service, PlayStation Now. Euromonitor International’s ...  |  read more...
USD 520
Gouty Arthritis (Gout)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... and marketed drugs across the Gouty Arthritis (Gout). A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions ...  |  read more...
USD 2,000
Global Savory Snacks Market: News and Events December 2014
2/6/2015 | published by: Canadean Ltd
... this report, marketers will effectively gain an insight into the latest happenings in the global savory snacks market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep ...  |  read more...
USD 295
Global Skincare Market: News and Events December 2014
2/6/2015 | published by: Canadean Ltd
... marketers will effectively gain an insight into the latest happenings in the global skincare market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest ...  |  read more...
USD 295
Cystic Fibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Cystic Fibrosis. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Cysticercosis (Taeniasis)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Cysticercosis (Taeniasis). A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Depression-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Depression. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Depression. ...  |  read more...
USD 2,000
Global Savory & Deli Foods Market: Merger and Acquisitions December 2014
2/6/2015 | published by: Canadean Ltd
... global savory & deli foods market during December 2014. Key Findings Using this report, dealmakers will effectively gain an insight into deal activity of the global savory & deli foods market throughout the month. Additionally, ...  |  read more...
USD 295
Erectile Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Erectile Dysfunction. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Dermatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Dermatitis. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Dermatitis. ...  |  read more...
USD 2,000
Diabetic Foot Infection (DFI)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... pipeline drugs and marketed drugs across the Diabetic Foot Infection (DFI). A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different ...  |  read more...
USD 2,000
Diabetic Nephropathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Diabetic Nephropathy. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Diabetic Neuropathic Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... and marketed drugs across the Diabetic Neuropathic Pain. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions ...  |  read more...
USD 2,000
Diabetic Neuropathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Diabetic Neuropathy. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Diabetic Peripheral Neuropathy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... and marketed drugs across the Diabetic Peripheral Neuropathy. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions ...  |  read more...
USD 2,000
Dyskinesia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Dyskinesia. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Dyskinesia. ...  |  read more...
USD 2,000
Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Dyslipidemia. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Dyslipidemia. ...  |  read more...
USD 2,000
Dysuria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... the Dysuria. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs falling under Dysuria. ...  |  read more...
USD 2,000
Severe Psoriasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015
2/6/2015 | published by: DelveInsight
... drugs across the Severe Psoriasis. A key objective of DelveInsight’s report is to establish the understanding for API Manufacturers for marketed and Phase III Pipeline drugs across the different countries and regions for the drugs ...  |  read more...
USD 2,000
Global Oral Hygiene Market: Merger and Acquisitions December 2014
2/6/2015 | published by: Canadean Ltd
... hygiene market during December 2014. Key Findings Using this report, dealmakers will effectively gain an insight into deal activity of the global oral hygiene market throughout the month. Additionally, the report provides an overview of ...  |  read more...
USD 295
5  6  7  8    10    12  13  14